http://publicationslist.org/data/naldi.luigi/atom.xml Naldi Luigihttp://publicationslist.org/naldi.luigi$basepathfavicon.icoRecent additions to Naldi Luigi's PublicationsList.org pagehttp://publicationslist.org/publications.png2007-10-13T07:09:01Z http://publicationslist.org/naldi.luigi/refid4 2007-10-13T07:08:22Z

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe cutaneous adverse reactions (SCAR) related to a variety of medications. They have a significant public health impact because of high mortality and morbidity. A multinational case-control study conducted in Europe between 1997 and 2001 evaluated the risk of medications to induce SCAR. Cases were actively detecte...<br/><br/> Mockenhaupt, Viboud, Dunant, Naldi, Halevy, Bavinck, Sidoroff, Schneck, Roujeau, Flahault (2007) <i>J Invest Dermatol</i> <i></i> <i></i> : <br/>

http://publicationslist.org/naldi.luigi/refid3 2007-10-13T07:08:22Z

Background Acute generalized exanthematous pustulosis (AGEP) is a disease characterized by the rapid occurrence of many sterile, nonfollicular pustules usually arising on an oedematous erythema often accompanied by leucocytosis and fever. It is usually attributed to drugs. Objectives To evaluate the risk for different drugs of causing AGEP. Patients and methods A multinational case-control study (...<br/><br/> Sidoroff, Dunant, Viboud, Halevy, Bavinck, Naldi, Mockenhaupt, Fagot, Roujeau (2007) <i>Br J Dermatol</i> <i></i> <i></i> : <br/>

http://publicationslist.org/naldi.luigi/refid2 2007-10-13T07:08:22Z

Luigi Naldi (2007) <i>Dermatology</i> <i></i> <i></i> 215: 4 273-276<br/>

http://publicationslist.org/naldi.luigi/refid1 2007-10-13T07:08:22Z

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare severe cutaneous adverse reactions. OBJECTIVES: We sought to update knowledge on the causes of SJS or TEN with a focus on the rate of allopurinol-associated cases and to identify risk factors for allopurinol-associated SJS or TEN. METHODS: We conducted a multinational case-control study. RESULTS: In all, 379 p...<br/><br/> Halevy, Ghislain, Mockenhaupt, Fagot, Bouwes Bavinck, Sidoroff, Naldi, Dunant, Viboud, Roujeau (2007) <i>J Am Acad Dermatol</i> <i></i> <i></i> : <br/>

http://publicationslist.org/naldi.luigi/refid5 2007-10-13T07:08:22Z

BACKGROUND: Few studies on the prevalence and incidence of many skin conditions in the general population are available because it is difficult to submit to dermatologic examination large samples of seemingly healthy population. OBJECTIVE: The aim of this study was to estimate the prevalence of several skin conditions among a sample that is deemed to be representative of the general population of ...<br/><br/>V Ingordo, C Gentile, S S Iannazzone, F Cusano, L Naldi (2007) <i>J Eur Acad Dermatol Venereol</i> <i></i> <i></i> 21: 8 1091-1096<br/>

http://publicationslist.org/naldi.luigi/refid6 2007-10-13T07:08:22Z

Scanty information is available on the relation between nevus count on specific anatomic areas and the total body surface, particularly in children. The authors analyzed this issue by using data from a uniquely large study conducted in 1997 on 3,406 schoolchildren (1,746 boys and 1,660 girls) aged 13-14 years in 13 cities from northern, central, and southern Italy. Children were examined by traine...<br/><br/>Silvano Gallus, Luigi Naldi, Paolo Carli, Carlo La Vecchia (2007) <i>Am J Epidemiol</i> <i></i> <i></i> 166: 4 472-478<br/>

http://publicationslist.org/naldi.luigi/refid9 2007-10-13T07:08:22Z

A history of sunburns in early life nearly doubles the risk of developing malignant melanoma in adulthood. From 2001 to 2004, we conducted a cluster-randomized trial of an educational intervention to reduce sunburn rates (primary outcome) and improve sun-protection behavior (secondary outcome) in schoolchildren. A total of 122 Italian primary schools (grades 2 and 3) were randomized to receive, or...<br/><br/>Luigi Naldi, Liliane Chatenoud, Paola Bertuccio, Cornelia Zinetti, Anna Di Landro, Lorenza Scotti, Carlo La Vecchia (2007) <i>J Invest Dermatol</i> <i></i> <i></i> 127: 8 1871-1877<br/>

http://publicationslist.org/naldi.luigi/refid8 2007-10-13T07:08:22Z

BACKGROUND: Overexpression of cyclooxygenase-2 (COX-2), resulting in excessive prostaglandin production, has been observed in human epidermal keratinocytes after ultraviolet B injury, in squamous cell skin carcinoma (SCC), in actinic keratoses, and in the early stages of carcinogenesis in a wide variety of tissues. The dysregulation of COX-2 expression can in part be due to functional changes affe...<br/><br/>M Gomez Lira, S Mazzola, G Tessari, G Malerba, M Ortombina, L Naldi, G Remuzzi, L Boschiero, A Forni, C Rugiu, S Piaserico, G Girolomoni, A Turco (2007) <i>Br J Dermatol</i> <i></i> <i></i> 157: 1 49-57<br/>

http://publicationslist.org/naldi.luigi/refid7 2007-10-13T07:08:22Z

A 61-year-old Italian man, who underwent a renal transplantation 8 years ago, receiving azathioprine, prednisone, and cyclosporine for immunosuppressive therapy, presented with a large reddish indurated plaque with a central ulcer, which was slowly enlarged, on the right knee. From the diseased tissue biopsy, a dematiaceous fungus matching Alternaria alternata in all essential characters was isola...<br/><br/>C Farina, E Gotti, A Parma, L Naldi, A Goglio (2007) <i>Transplant Proc</i> <i></i> <i></i> 39: 5 1655-1659<br/>

http://publicationslist.org/naldi.luigi/refid10 2007-10-13T07:08:22Z

This study examines the association of keratotic skin lesions with the development of skin cancer in 915 solid organ-transplant recipients in five European countries. In a hospital-based case-control study, cases with squamous- and basal-cell carcinoma were compared with controls without skin cancer. Questionnaires, scrutiny of medical charts, and skin examination were delivered according to a sta...<br/><br/>Jan N Bouwes Bavinck, Sylvie Euvrard, Luigi Naldi, Ingo Nindl, Charlotte M Proby, Rachel Neale, Damiano Abeni, Gian P Tessari, Mariet C W Feltkamp, Alain Claudy, Eggert Stockfleth, Catherine A Harwood (2007) <i>J Invest Dermatol</i> <i></i> <i></i> 127: 7 1647-1656<br/>